Filing Flows › NexPoint Residential Trust (NXRT) › Stock forecast & fair value
NexPoint Residential Trust (NXRT) stock forecast and fair value
NexPoint Residential Trust (NXRT) trades at $19.35. 4 analysts' median price target is $24.00 (+24%), from $18.00 to $35.00. Across 17 valuation methods the middle fair value is $20.15 (+4%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| EV/EBITDA vs peers | −$5.88 | $9.44 | $30.25 | -51% |
| EV/EBITDA vs peers, weighted | $10.06 | $29.07 | $48.75 | +50% |
| EV/EBITDA vs peers, matched | −$8.81 | $6.56 | $10.11 | -66% |
| EV/Sales vs peers | −$22.86 | $24.96 | $51.16 | +29% |
| EV/Sales vs peers, weighted | $23.81 | $54.14 | $76.54 | +180% |
| EV/Sales vs peers, growth & margin adjusted | −$25.57 | −$10.34 | $11.10 | -153% |
| Residual income | $2.55 | $2.65 | $2.77 | -86% |
| P/FFO vs REIT peers | $1.77 | $2.10 | $2.98 | -89% |
| P/FFO vs REIT peers, weighted | $2.08 | $2.68 | $3.82 | -86% |
| Analysts' price targets | $18.00 | $25.25 | $35.00 | +30% |
NexPoint Residential Trust's latest quarter
NexPoint Residential Trust, Q3 2026: revenue $64.5M (+3% year over year), operating margin 9.9%, net loss $11.5M, operating cash flow $20.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NXRT stock?
The median of 4 analysts' 12-month targets is $24.00, +24% from $19.35; the range is $18.00 to $35.00. The average rating is none.
What is NexPoint Residential Trust's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between −$33.05 and $54.14, with a middle value of $20.15 against a price of $19.35. Each method's assumptions are on the page.
Does NexPoint Residential Trust usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is NXRT stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.